Quick Summary
Medication-Assisted Treatment, often shortened to MAT or MOUD (Medications for Opioid Use Disorder), combines FDA-approved medications with counseling and behavioral support. Methadone, buprenorphine, and naltrexone are the three medications used most often. SAMHSA and the National Institute on Drug Abuse describe this combination as one of the most effective approaches to opioid use disorder available today.
Key Takeaways
- Three FDA-approved medications treat opioid use disorder: methadone, buprenorphine, and naltrexone.
- Methadone and buprenorphine have been shown to reduce opioid overdose deaths significantly compared to no medication treatment.
- MAT pairs medication with counseling, recovery support, and ongoing care for the best outcomes.
- Medication decisions are individualized and made with a qualified prescriber, not based on general articles.
- SAMHSA and NIDA have shifted toward the term MOUD to emphasize that these medications treat the disorder, not just assist treatment.
Medication-Assisted Treatment is a phrase that can sound clinical and intimidating among the many treatment options available. The reality is more grounded. It means using FDA-approved medications, alongside counseling and recovery support, to treat opioid use disorder. The evidence base has grown over the last two decades to the point where major federal agencies including SAMHSA and the National Institute on Drug Abuse describe these medications as a core part of effective treatment.
The Three Medications
Methadone
Methadone is a long-acting opioid agonist that reduces cravings and withdrawal without producing the high associated with shorter-acting opioids like heroin or fentanyl. It has been used to treat opioid use disorder for more than fifty years. In the United States it is dispensed through certified opioid treatment programs.
Buprenorphine
Buprenorphine is a partial opioid agonist that also reduces cravings and withdrawal with a lower risk of misuse than full agonists. It can be prescribed by qualified clinicians in office-based settings, which makes it more accessible than methadone for many people. The FDA publishes detailed prescribing information.
Naltrexone
Naltrexone is an opioid antagonist that blocks opioid receptors. It is available as a daily pill or a monthly injection. Because it blocks effects rather than reducing cravings the way methadone or buprenorphine do, retention is typically lower and people who relapse face increased overdose risk due to lost tolerance.
What the Evidence Shows
People with opioid use disorder who take prescribed methadone or buprenorphine are roughly half as likely to die of overdose as those receiving no medication (Sordo et al., 2017). In one large observational study of people who had survived an overdose, methadone was associated with about a 59 percent reduction in opioid-related deaths and buprenorphine with about a 38 percent reduction, each compared with receiving no medication (Larochelle et al., 2018). Because each medication was compared with no treatment rather than with the other, these figures are not a head-to-head verdict that one is better than the other. The evidence for naltrexone on overdose prevention is weaker and its retention lower, largely because of the opioid-free start it requires; once successfully initiated, extended-release naltrexone was about as effective as buprenorphine-naloxone at preventing relapse in the X:BOT trial.
We’re here to make treatment as accessible and affordable as possible — and are in network with many insurance providers. Not sure about your coverage? We can help.
How MAT Fits Into Treatment
Medication is one part of the picture. Effective MAT combines the medication with counseling (individual or group), peer recovery support, treatment for any co-occurring mental health conditions, and coordination of physical health care. The combination is what produces the best outcomes. Counseling helps people build the skills and supports that medication alone cannot provide.
Common Misconceptions
“Replacing one drug with another.” Methadone and buprenorphine activate opioid receptors but do so in a way that stabilizes the brain and removes the chaos of withdrawal and cravings. People on MAT can hold jobs, raise families, and function normally. This is treatment, not substitution in the harmful sense.
“You have to be on MAT forever.” Length of treatment is individualized. Some people use medications for months, others for years, others indefinitely. The decision is made between a person and their prescriber based on stability, risks, and goals.
“MAT is just for severe cases.” MAT is appropriate for many people with opioid use disorder, not just the most severe. A clinical assessment can help determine fit.
Talking With a Professional
If you or someone you love is considering MAT, the next step is talking with a qualified clinician. They can run an assessment, talk through which medication may fit best, and explain what counseling and support will look like alongside it. The admissions team at Discovery Point Retreat can help you understand what an assessment involves and what options exist.
References
- Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137-145. NIH summary.
- Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550. Full text.
- Lee JD, Nunes EV, Novo P, et al. Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT). Lancet. 2018;391(10118):309-318. Full text.
- Substance Abuse and Mental Health Services Administration. TIP 63: Medications for Opioid Use Disorder. Accessed June 8, 2026. samhsa.gov.
- National Institute on Drug Abuse. Medications to treat opioid use disorder. Accessed June 8, 2026. nida.nih.gov.
Resources
- 988 Suicide and Crisis Lifeline. Call or text 988, or chat at 988lifeline.org. Free, confidential support 24/7.
- SAMHSA National Helpline. Call 1-800-662-HELP (4357) or visit the SAMHSA National Helpline page for free, confidential referrals to local treatment.
- 911. For any medical emergency, including suspected overdose or withdrawal complications, call 911 immediately. If naloxone is available for a suspected opioid overdose, administer it according to the package instructions while waiting for help.
This article is general education and is not medical advice. It does not establish a clinician-patient relationship and is not a substitute for an individual assessment by a qualified mental health or addiction treatment professional.
